Preferred Label : Bevacizumab/Erlotinib Regimen;
NCIt synonyms : Bevacizumab Erlotinib; Avastin/Tarceva; Erlotinib/Bevacizumab Regimen; Tarceva/Avastin; Erlotinib-Bevacizumab; Avastin-Tarceva; Erlotinib/Bevacizumab; Bevacizumab-Erlotinib; Bevacizumab-Erlotinib Regimen;
NCIt related terms : Erlotinib and Bevacizumab; Erlotinib and Bevacizumab-aybi; Erlotinib and Bevacizumab-awwb; Erlotinib and Bevacizumab-equi; Erlotinib and Bevacizumab-adcd; Erlotinib and Bevacizumab-bvzr; Erlotinib and Bevacizumab-maly; Erlotinib and Bevacizumab-onbe;
NCIt definition : A regimen consisting of bevacizumab and erlotinib that may be used in the treatment
of epidermal growth factor receptor (EGFR)-positive kidney cancer and non-small cell
lung cancer (NSCLC).;
Codes from synonyms : 2587; 127608; 127460; 127164; 127386; 127312; 127534; 127238;
Origin ID : C37557;
UMLS CUI : C1327881;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
